VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chron...
Revenues increased by 384% year over year Debt ratio decreased to 7% from 75% at year-end 2021 SAN...
The FDA gave positive feedback regarding filing a Biologics License Application (BLA) for Sjögren's...